Ischemic Vasculopathy
Ischemic Vasculopathy - Related Videos
08:32
Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy
0 Views •
Cited by 7 •
2010
This video demonstrates the orthotopic aortic transplant model as a simple model to study the development of transplant vasculopathy (TVP) in rats.
08:47
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
0 Views •
Cited by 48 •
2008
The postnatal rat model for hypoxic-ischemic brain injury is a well-established model of human neonatal hypoxic ischemic encephalopathy (HIE). In this article, we describe the model of HIE in post-natal rat pups.
08:35
Demonstration of the Rat Ischemic Skin Wound Model
0 Views •
Cited by 32 •
2015
The rat, due to its size, availability, and rather docile behavior, has been utilized as a research model for many years. The goal of this protocol is to utilize the rat as an ischemic skin wound healing model to provide valuable insight into the pathophysiology of chronic wounds.
12:00
A Simplified Technique for Producing an Ischemic Wound Model
0 Views •
Cited by 22 •
2012
We have developed a minimally invasive technique to create a rabbit ischemic ear wound model by dividing the central artery and nerve and the cranial neurovascular bundle. A subcutaneous tunnel then cuts all subcutaneous tissues. This procedure causes minimal skin disruption and can be safely used in diabetic animals.
15:08
Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
0 Views •
Cited by 13 •
2017
Ischemic stroke is a complex event in which the specific contribution of astrocytes to the affected brain region exposed to oxygen glucose deprivation (OGD) is difficult to study. This article introduces a methodology to obtain isolated astrocytes and study their reactivity and proliferation under OGD conditions.
FAQs
Thrombosis can obstruct an already narrowed vessel or create a new blockage, sharply reducing downstream perfusion. Occlusion prevents adequate delivery of oxygen and nutrients, so affected tissue may progress from pain or injury to ulceration or necrosis. Recognizing this mechanism matters because treatment may need to target thrombosis while also addressing other contributors to impaired circulation.
Endothelial dysfunction can impair the normal behavior of the vessel lining and contribute to reduced blood flow. In the broader pattern of ischemic vasculopathy, it may coexist with narrowing, thrombosis, inflammation, or occlusion rather than acting as an isolated abnormality. Identifying it helps clinicians consider vascular mechanisms beyond a single visible blockage when evaluating tissue injury.
The key distinction is evidence of impaired vascular perfusion as the driver of tissue injury. Pain, ulcers, or necrosis can occur in more than one clinical setting, so clinicians assess whether vessel narrowing, occlusion, thrombosis, inflammation, or endothelial dysfunction better explains the findings. This distinction helps separate vascular insufficiency from other causes and supports more targeted evaluation and management.
Clinical examination provides the initial assessment of tissue changes and possible perfusion problems. Vascular imaging can then evaluate abnormalities in the circulation, while laboratory testing helps investigate relevant underlying causes. Using these approaches together gives clinicians complementary information rather than relying on one test, helping determine whether vascular insufficiency is contributing to pain, tissue injury, ulcers, or necrosis.
Treatment is guided by the underlying mechanism rather than by tissue injury alone. Depending on the cause, management may target thrombosis, inflammation, cardiovascular risk factors, or impaired circulation. This cause-directed approach aims to prevent progression and preserve tissue viability, while also addressing the vascular abnormality responsible for inadequate oxygen and nutrient delivery.
Prompt recognition can help identify vascular insufficiency before tissue damage becomes irreversible. Evaluation clarifies whether the process is associated with narrowing, occlusion, thrombosis, inflammation, or endothelial dysfunction, while management focuses on the relevant cause. Together, these steps may limit progression from pain or injury toward ulcers and necrosis and support preservation of affected skin or organ tissue.